Anti-obesity proposal fails again at McDonald's

Key points
- McDonald's Corp investors soundly rejected a shareholder proposal that would have required the world's biggest fast-food chain to assess its impact on childhood obesity.
- As one of the largest and most influential companies in the restaurant industry, McDonald's often bears the brunt of criticism from consumers, parents and healthcare professionals, who want it to serve healthier food and curb its marketing to children.
- Childhood obesity has more than tripled in the past 30 years.
- The subject was a major topic of discussion at Thursday's annual shareholder meeting, which also served as a send-off for retiring Chief Executive Jim Skinner - whose nearly eight years at the helm will be remembered as a time when the price of McDonald's stock tripled.
McDonald's Corp investors soundly rejected a shareholder proposal that would have required the world's biggest fast-food chain to assess its impact on childhood obesity.
The subject was a major topic of discussion at Thursday's annual shareholder meeting, which also served as a send-off for retiring Chief Executive Jim Skinner - whose nearly eight years at the helm will be remembered as a time when the price of McDonald's stock tripled.
The shareholder proposal, which also failed last year, returned amid growing concern over the social and financial costs of obesity in the United States and around the world - not only in terms of healthcare-related expenses but also lower worker productivity and diminished quality of life.
Nearly one-third of U.S. children are overweight or obese. America is one of the fattest nations on earth, and the Institute of Medicine, in a 2006 report requested by Congress, said junk food marketing contributes to an epidemic of childhood obesity that continues to rise. The institute is the health arm of the National Academy of Sciences.
McDonald's executives on Thursday defended the brand and its advertising.
"We're proud of the changes we've made to our menu. We've done more than anybody in the industry around fruits and vegetables and variety and choice," said Skinner, who will retire on June 30 and who received a standing ovation from investors.
McDONALD'S HEALTH FOOTPRINT
As one of the largest and most influential companies in the restaurant industry, McDonald's often bears the brunt of criticism from consumers, parents and healthcare professionals, who want it to serve healthier food and curb its marketing to children.
McDonald's stockholders reject obesity proposal McDonald's Corp spurned calls to assess the impact of its food on childhood obesity, and said its trademark clown Ronald McDonald would be hawking Happy Meals to kids for years to come.
"This is about choice and we believe in the democratic process," Chief Executive Jim Skinner told a packed room at its shareholders' meeting, to an enthusiastic wave of applause. "This is about the personal and individual right to choose."
Shareholders of the world's largest fast-food chain resoundingly rejected a proposal that would have required it to issue a report outlining its role in the childhood obesity epidemic, saying customers were free to make their own dietary choices.
"Ronald McDonald is an ambassador to McDonald's and he is an ambassador for good. Ronald McDonald is going nowhere," Skinner said firmly, prompting more cheers from shareholders.
Among the dissenters at the meeting was Dr. Donald Zeigler, director of Prevention and Health Lifestyles at the American Medical Association, who asked when the burger chain will stop marketing to children using Ronald McDonald.
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Weight & Nutrition →
NewsEU warns consumers about fake anti-obesity drug
Fake versions of rimonabant, an anti-obesity drug are being sold on the Internet. Plus, the drug has not been approved for sale in the European Union, the European Commission warned consumers on Monday. Fakes of the…
29 March 2006
NewsThe pros and cons of new anti-obesity drug
According to researchers at New York's Columbia University College of Physicians and Surgeons, an anti-obesity drug that turns off the same brain circuits which trigger the marijuana-induced hunger pangs, appears to…
17 February 2006
NewsAnti-obesity pill reduces weight, improves lipids
In a 2-year study of overweight or obese subjects, a marijuana derivative, or cannabinoid, called rimonabant (Acomplia) helped those who took it lose weight and improve their cardiovascular risk profile. Weight loss…
16 February 2006


